Mercury(II)<i>p</i>-toluenesulfonamidate

Montaña, Ángel M.; Corominas, Albert

doi:10.1002/047084289x.rn01534

Encyclopedia of Reagents for Organic Synthesis 2013

DOI: 10.1002/047084289x.rn01534

|View full text |Cite

Mercury(II)p-toluenesulfonamidate

Ángel M. Montaña

Albert Corominas

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2018

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Synthesis of the 10-oxabicyclo[5.2.1]decane framework present in bioactive natural products

Montaña

Ponzano²,

Sanasi

et al. 2018

Org. Biomol. Chem.

View full text Add to dashboard Cite

The present work deals with the synthesis of the 10-oxabicyclo[5.2.1]decane framework present in bioactive natural products like physalins, with potential as antitumor agents. This synthetic methodology involves several key reactions: (a) synthesis of polyfunctionalized cycloheptenones by [4 + 3] cycloaddition reactions of furan precursors with oxyallyl cations; (b) Nicholas reaction with propargyl cations stabilized as dicobalt hexacarbonyl complexes; (c) demetallation and hydration of the resulting acetylenes; (d) stereoconvergent aldol cyclization to generate a key oxatricyclic intermediate and (e) a β-fragmentation process that affords, under hypoiodite photolysis, the desired product with moderate to good yield. The final compounds are the result of a radicalary β-fragmentation at the level of C2-C6 with respect to the tertiary hydroxyl group on C6, with an unexpected contraction from a ten- to a nine-membered ring system, via a radical addition to the carbonyl group on C4. The synthetic methodology has been scaled up to multigram level with good overall yield. Further biological, biochemical and biophysical studies are being carried out in our laboratory on these 1,7-epoxycyclononane derivatives to determine the potential of this kind of oxabicyclic compound as future hits and/or leads for the development of new anticancer drugs. The preliminary evaluation of the anticancer activity of the representative synthesized compounds, against the leukaemia cancer cell lines K-562 and SR, shows a promising activity with a GI = 0.01 μM and a LC = 7.4 μM for a conveniently functionalized 10-oxabicyclo[5.2.1]decane.

show abstract

Synthesis of the 10-oxabicyclo[5.2.1]decane framework present in bioactive natural products

Montaña

Ponzano²,

Sanasi

et al. 2018

Org. Biomol. Chem.

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Mercury(II)p-toluenesulfonamidate

Cited by 1 publication

References 22 publications

Synthesis of the 10-oxabicyclo[5.2.1]decane framework present in bioactive natural products

Synthesis of the 10-oxabicyclo[5.2.1]decane framework present in bioactive natural products

Contact Info

Product

Resources

About